Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
BACKGROUND: Buruli ulcer (BU) is an emerging infectious disease caused by Mycobacterium ulcerans that can result in extensive necrotizing cutaneous lesions due to the cytotoxic exotoxin mycolactone. There is no specific vaccine against BU but reports show some degree of cross-reactive protection con...
Main Authors: | Alexandra G Fraga, Teresa G Martins, Egídio Torrado, Kris Huygen, Françoise Portaels, Manuel T Silva, António G Castro, Jorge Pedrosa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3297633?pdf=render |
Similar Items
-
Aquatic insects and Mycobacterium ulcerans: an association relevant to Buruli ulcer control?
by: Manuel T Silva, et al.
Published: (2007-02-01) -
Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
by: Nicholas J Tobias, et al.
Published: (2009-01-01) -
Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against Mycobacterium ulcerans
by: Juan Dominguez, et al.
Published: (2023-09-01) -
Correction: Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer
Published: (2010-02-01) -
Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control.
by: Paul D R Johnson, et al.
Published: (2005-04-01)